(NASDAQ:BLLN), MENLO PARK, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) — BillionToOne, Inc. (NASDAQ: BLLN), a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for third quarter ended September 30, 2025 after the market close on […]
In its second annual Mac Admins Survey, MacPaw's CleanMyMac Business team uncovers the top trends emerging in 2025, including device lifecycles, cybersecurity, and AI integration MacPaw,a leading macOS and iOS software developer, today released the second annual Mac Admins Survey, conducted by the team behind CleanMyMacBusiness. The survey gathered insights from nearly 400 Mac administrators
Affluent Families Embrace Resilience Strategies Amid Property Market Stress, RisingDigital Threats, and Shifting Risk Appetite HUB International Limited(HUB), a leading global insurance brokerage and financial services firm, today released the 2026 HUB Private Client Outlook, highlighting how high-net-worth (HNW) individuals and families are navigating the current insurance market and redefining how they approach risk. https://mma.prnewswire.com/media/2835847/Outlook_26_Private_Client_PR_Graphic.jpg
Carta Healthcare, a leading provider of AI-powered clinical data abstraction solutions, today announced a strategic partnership with Fivos, a leading provider of data solutions for medical research organizations and device manufacturers, as well as the clinical data registry provider for the Society for Vascular Surgery's Vascular Quality Initiative (SVS VQI®). https://mma.prnewswire.com/media/2480470/Carta_Healthcare__Logo.jpg Fivos has selected Carta
Accord Healthcare, Inc., a leading generic pharmaceutical company committed to improving access to affordable medicines, today announced the launch of Clomiphene tablets, the generic equivalent of CLOMID® (clomiphene citrate). This new product strengthens Accord Healthcare's growing women's health portfolio and emphasizes its mission to broaden patient access to safe, effective, and affordable treatment options. https://mma.prnewswire.com/media/2835384/Accord_Logo.jpg
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization GlobeNewswire December 02, 2025 SHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp. (“BGLC” or the “Company“), an emerging provider of precision oncology diagnostics with expanding
SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9-10, 2025 GlobeNewswire December 02, 2025 COMMACK, NY, Dec. 02, 2025 (GLOBE NEWSWIRE) — SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 GlobeNewswire December 02, 2025 MENLO PARK, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) — BillionToOne, Inc. (NASDAQ: BLLN), a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release
Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy GlobeNewswire December 02, 2025 RICHMOND, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) — Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ST-503,
Pioneering the Future of Sustainable Flight Training with Advanced Carbon Fiber Innovation Bye Aerospace, Inc., a global leader in electric aviation, announced a groundbreaking partnership with Composite Approach, a premier carbon fiber prototyping and manufacturing company, to build the first structural composite aircraft for the eFlyer 2 inaugural electric flight. The eFlyer series aims to